Abstract
N1-methylnicotinamide (NMN) and p-aminohippurate (PAH) transport can be reconstituted in phospholipid vesicles by incorporating the solubilized membrane proteins into artificial phospholipid membranes. After solubilization with the non-ionic detergent, Lubrol WX, the protein solution was added to a phospholipid solution (prepared by dissolving the phospholipids in the detergents) and the phospholipid:protein vesicles were allowed to form during dialysis. Transport in these vesicles was studied with radioactively labeled NMN or PAH; the transport for NMN was 173 to 394 pmoles/mg of protein/5 min and for PAH was 263 to 505 pmoles/mg of protein/5 min. Transport into control vesicles (without protein) was less than 10% of these values. The transport of NMN and PAH displayed properties of facilitated diffusion: 1) equilibrium was reached within 5 min; 2) pH dependence (optimum for NMN was 7.4, for PAH, 7.0); 3) protein and lipid concentration dependence; 4) saturability (Km estimated from ½ saturation was approximately 1 mM for both NMN and PAH); and 5) specificity, in that known competitors of these transport systems inhibited uptake. In addition, it appears as if specific phospholipids are required in that only sphingomyelin and phosphatidylcholine functioned in reconstituting transport. Using reconstitution as the mode of assaying the proteins through an isolation procedure after solubilization, we achieved a 45 fold purification of the NMN and PAH transport proteins. Interestingly, although our data clearly show that the two transport systems are distinct entities, the two activities copurify. Based upon these results, we propose that we have accomplished a partial purification of the "carrier" proteins involved in the renal secretion of organic compounds.
ACKNOWLEDGMENTS The authors would like to thank Dr. A. R. Bassel for the electron microscopy, Drs. J. D. Robinson and I. M. Weiner for their critical reading of this manuscript and to Dorothy Stechyshyn for typing it.
- Copyright © 1979 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|